Xentuzumab
Product Specifications
CAS Number
1417158-65-6
Target
Akt, IGF-1R
Related Pathways
PI3K/Akt/mTOR signaling, Tyrosine Kinase/Adaptors, Cytoskeletal Signaling
Purity
0.9521
Bioactivity
Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A13306-2-Dylight550 100 µg
Anti-SYT16 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details